Indies Pharma Jamaica Limited (JMSE:INDIES)

Jamaica flag Jamaica · Delayed Price · Currency is JMD
2.960
-0.020 (-0.67%)
At close: Mar 24, 2026
Market Cap3.94B -4.8%
Revenue (ttm)1.08B -2.8%
Net Income128.86M -18.0%
EPS0.10 -18.0%
Shares Out1.33B
PE Ratio30.81
Forward PEn/a
Dividend0.14 (4.53%)
Ex-Dividend DateApr 9, 2026
Volume1,524,862
Average Volume172,580
Openn/a
Previous Close2.980
Day's Range2.850 - 3.000
52-Week Range2.330 - 3.400
Beta0.14
RSI53.27
Earnings DateMar 13, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 64
Stock Exchange Jamaica Stock Exchange
Ticker Symbol INDIES
Full Company Profile

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.

Financial Statements